Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variation

Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variation

US Patent 10961583 · Granted Mar 30, 2021

Estimated economic value: $202,328,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-MSR1 antibodies and methods of use thereof2025
Treatment of respiratory disorders with arachidonate 15-lipoxygenase (ALOX15) in2025
Treatment of sepsis with PCSK9 and LDLR modulators2025
Materials and methods of treating MHC-I-opathy risk haplotypes2025
Nucleic acids encoding anchor modified antibodies and uses thereof2025
Methods of treatment using a leptin receptor agonist antibody2025
17ß-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and method2025
17ß-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and method2025
17ß-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and method2025
17ß-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and method2025
17ß-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and method2025
17ß-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and method2025